Characteristics of [14C]Guanidinium Accumulation in NG 108‐15 Cell Exposed to Serotonin 5‐HT3 Receptor Ligands and Substance P
暂无分享,去创建一个
M. Riad | M. Hamon | M. Emerit | M Hamon | M Riad | M B Emerit | C M Fattaccini | C. Fattaccini | M. Hamon
[1] R. North,et al. 5-HT3 receptors are membrane ion channels , 1989, Nature.
[2] J. Garthwaite,et al. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.
[3] J. Plomp,et al. Kinetics of the membrane current mediated by serotonin 5‐HT3 receptors in cultured mouse neuroblastoma cells. , 1989, The Journal of physiology.
[4] D. Lovinger. Ethanol potentiation of 5-HT3 receptor-mediated ion current in NCB-20 neuroblastoma cells , 1991, Neuroscience Letters.
[5] H. Higashi,et al. 5‐Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia , 1982, The Journal of physiology.
[6] D. Lodge,et al. Noncompetitive excitatory amino acid receptor antagonists. , 1990, Trends in pharmacological sciences.
[7] J. A. Peters,et al. Physiological and pharmacological properties of 5-HT3 receptors — A patch clamp-study , 1991, Neuropeptides.
[8] M. Reith,et al. [14C]guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex. , 1990, European journal of pharmacology.
[9] T. Dwyer,et al. The permeability of the endplate channel to organic cations in frog muscle , 1980, The Journal of general physiology.
[10] M. Jackson,et al. The selectivity of the channel coupled to the 5-HT3 receptor , 1990, Brain Research.
[11] J. A. Peters,et al. The properties of 5‐HT3 receptors in clonal cell lines studied by patch‐clamp techniques , 1989, British journal of pharmacology.
[12] M. Jackson,et al. Differentiation of NG108-15 cells alters channel conductance and desensitization kinetics of the 5-HT3 receptor. , 1991, Journal of neurophysiology.
[13] B. Hamprecht. Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. , 1977, International review of cytology.
[14] B. Costall,et al. [3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition Sites , 1988, The Journal of pharmacy and pharmacology.
[15] T. Narahashi,et al. Cation selectivity of acetylcholine-activated ionic channel of frog endplate , 1979, The Journal of general physiology.
[16] I. Martin,et al. Molecular biology of 5-HT receptors , 1994, Neuropharmacology.
[17] G. Reiser,et al. Characterization of a substance P receptor activating a cation permeability in neuronal cell lines. , 1988, European journal of pharmacology.
[18] G. Reiser,et al. Serotonin raises the cyclic GMP level in a neuronal cell line via 5-HT3 receptors. , 1989, European journal of pharmacology.
[19] J. Yang,et al. Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells , 1990, The Journal of general physiology.
[20] S. Zukin,et al. Kinetic mechanisms of glycine requirement for N-methyl-d-aspartate channel activation , 1991, Brain Research.
[21] B. Costall,et al. Agonist interactions with 5‐HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands , 1992, British journal of pharmacology.
[22] J. Bockaert,et al. Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80 , 1990, FEBS letters.
[23] J. Bockaert,et al. Interaction of substance P, compound 4880 and mastoparan with the α-subunit C-terminus of G protein , 1990 .
[24] P. Hartig. Molecular biology of 5-HT receptors. , 1989, Trends in pharmacological sciences.
[25] R. Myers,et al. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.
[26] J. Bockaert,et al. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. , 1990, Immunology letters.
[27] J. Lowe,et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.
[28] A. Round,et al. Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists , 1987, Neuropharmacology.
[29] B. Richardson,et al. The pharmacology and function of 5-HT3receptors , 1986, Trends in Neurosciences.
[30] S. Watson,et al. Tachykinin receptor types: Classification and membrane signalling mechanisms , 1991, Neurochemistry International.
[31] G. Reiser,et al. Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line , 1989, Brain Research.
[32] R. North,et al. The action of 5-hydroxytryptamine on single neurones of the rabbit superior cervical ganglion , 1978, Neuropharmacology.
[33] E. Ross,et al. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). , 1988, The Journal of biological chemistry.
[34] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[35] M. B. Tyers,et al. Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve , 1987, British journal of pharmacology.
[36] A. Yang,et al. Influence of the freezing process upon fluoride binding to hemeproteins. , 1991, Biophysical journal.
[37] A. Surprenant,et al. Electrophysiological characterization of functionally distinct 5-hydroxytryptamine receptors on guinea-pig submucous plexus , 1988, Neuroscience.
[38] G. Reiser,et al. Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line. , 1989, European journal of pharmacology.
[39] M. Jackson,et al. 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line , 1988, Neuron.
[40] K. Watling. Radioligand binding studies identify 5-HT3 recognition sites in neuroblastoma cell lines and mammalian CNS. , 1988, Trends in pharmacological sciences.
[41] M. Hamon,et al. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. , 1990, Biochemical pharmacology.
[42] M. Hamon,et al. Physicochemical Properties of Serotonin 5‐HT3 Binding Sites Solubilized from Membranes of NG 108‐15 Neuroblastoma‐Glioma Cells , 1990, Journal of neurochemistry.
[43] Gavin Kilpatrick,et al. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.
[44] P. Krogsgaard‐Larsen. GABA and glutamate receptors as therapeutic targets in neurodegenerative disorders. , 1992, Pharmacology & toxicology.
[45] G. Reiser,et al. Serotonin regulates cytosolic Ca2+ activity and membrane potential in a neuronal and in a glial cell line via 5-HT3 and 5-HT2 receptors by different mechanisms. , 1989, Journal of cell science.
[46] C. Bronner,et al. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. , 1990, Trends in pharmacological sciences.